Vesalius Biocapital raises €120m

The Luxembourg-headquartered specialist life sciences venture capital firm closes third fund.

26 June 2019•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.